Læknablaðið : fylgirit - 01.05.1978, Qupperneq 143

Læknablaðið : fylgirit - 01.05.1978, Qupperneq 143
Gunnar Husby, Knut Sletten, Robin F. Anders, Jacob B. Natvig Institute of Immunology and Rheumatology, Rikshospitalet and Institute of Biochemistry, University of Oslo, Norway THE NATURE OF AMYLOID FIBRILS ASSOCIATED WITH RHEUMATIC DISORDERS The amyloid fibril (3) is the unique component of all types of amyloid substances. The ultra- structure of the fibrils is identical in different clinical categories of amyloidosis like primary, myelomaassociated and secondary amyloidosis as well as in spontaneous and experimental amyloidosis in animals. However, recent investigations have shown evidence that chemi- cally entirely different classes or proteins may make up amyloid fibrils with identical ultra- structure. It is interesting that the chemistry of the fibrils to a large extent follows the much older clinical classification of amyloidosis. Hence, it has been established that the protein most often found as the major subunit of primary and myelomaassociated amyloid fibrils is smaller or larger parts of monoclonal immunoglobulin light chains, particularly their amino-terminal, variable part (6,11). On the other hand, the completely different protein AA (for nomenclature, see 2) is consistently found as a major component of secondary amyloid fibrils (3,5,7,8,9,12,16). The present communication is concerned with the amyloid protein AA and a related serum protein SAA. In addition, we also report data on another major fibril component, the high molecular weight or "void volume" material which seems to be present in amyloid fibrils of both the immuno- globulin and the protein AA type. It is concluded that the amyloid protein AA as well as the void volume material of amyloid fibrils are protein components derived from connective tissue. Materials and methods Amyloid fibrils were prepared according to Pras et al. (14) from the liver of a patient T.H. with amyloidosis secondary to juvenile rheumatoid arthritis (JRA) and from the liver of a patient with amyloidosis associated with ankylosing spondylitis (AS). The fibrils were treated with 0.1 N sodium hydroxide for immunization of rabbits and for immunodifussion studies, and with 6 M guanidine/ 0.1 M dithiothreitol (DTT) for fractionation by gel filtration on Sephadex G-100 and G-25 columns as described in details previously (8). Amyloid fibril subfragments purified by gel filtration were studied by amino acid composition and sequence analyses (8,9,16,17) and by immuno- logic tests (8,9,11). For comparative studies tissues from corre- sponding normal organs were subjected to exactly the same procedures for extraction and chemical treatment as the amyloidotic organs, and to the same amino acid analyses and immunologic studies. Anti-amyloid antiserum was raised in rabbits by immunization with NaOH-treated amyloid fibrils (DAM) and made mono-specific for protein AA and the amyloid void volume material respectively by specific absorptions (8,9,11). Fig. 1 Gel filtration of amyloid T.H. liver. Two major peaks are obtained: The Vo-material, and at a later position the amy- loid protein AA. 141
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100
Qupperneq 101
Qupperneq 102
Qupperneq 103
Qupperneq 104
Qupperneq 105
Qupperneq 106
Qupperneq 107
Qupperneq 108
Qupperneq 109
Qupperneq 110
Qupperneq 111
Qupperneq 112
Qupperneq 113
Qupperneq 114
Qupperneq 115
Qupperneq 116
Qupperneq 117
Qupperneq 118
Qupperneq 119
Qupperneq 120
Qupperneq 121
Qupperneq 122
Qupperneq 123
Qupperneq 124
Qupperneq 125
Qupperneq 126
Qupperneq 127
Qupperneq 128
Qupperneq 129
Qupperneq 130
Qupperneq 131
Qupperneq 132
Qupperneq 133
Qupperneq 134
Qupperneq 135
Qupperneq 136
Qupperneq 137
Qupperneq 138
Qupperneq 139
Qupperneq 140
Qupperneq 141
Qupperneq 142
Qupperneq 143
Qupperneq 144
Qupperneq 145
Qupperneq 146
Qupperneq 147
Qupperneq 148
Qupperneq 149
Qupperneq 150
Qupperneq 151
Qupperneq 152
Qupperneq 153
Qupperneq 154
Qupperneq 155
Qupperneq 156
Qupperneq 157
Qupperneq 158

x

Læknablaðið : fylgirit

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið : fylgirit
https://timarit.is/publication/991

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.